Inhalation Sciences Sweden AB

Inhalation Sciences Sweden, ISAB, is a research company. The company focuses primarily on the production and development of laboratory instruments. The instruments are used to measure particles in inhaled air and how the composition of the air affects the lungs. The company sells products under various brands, mainly on the European market. Inhalation Sciences Sweden was founded in 2004 and is headquartered in Huddinge.

Quotes for Inhalation Sciences Sweden AB

Board

CEO

Manoush Masarrat

Chairperson of the Board

Jan Hellqvist

Board

Niklas Lindecrantz
Per Gerde
Ulf Ericsson

Articles of association

Videos

1 / 4

CommonQuestions Inhalation Sciences 240229

Interview Inhalation Sciences | VD Manoush Masarrat - "Samarbetet med FDA kommer ge större volymer"

CompanyPresentation Hemma hos Inhalation Sciences

Sitdown Inhalation sitdown

** Powered by Modular Finance

*Powered by Modular Finance

Key Numbers

	2026-03-31	2025-12-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Number of months that the report spans	Q1 3 Months	2025	Q4 3 Months	Q3 3 Months	Q2 3 Months	Q1 3 Months	2024
Total revenue MSEK	4.15	3.04	1.30	0.16	0.78	0.81	11.05
Earnings before interest and tax MSEK	-1.40	-10.16	-2.65	-2.77	-2.50	-2.24	-5.08
Profit before tax MSEK	-1.40	-10.16	-2.64	-2.77	-2.50	-2.25	-5.15
Net profit MSEK	-1.40	-10.16	-2.64	-2.77	-2.50	-2.25	-5.15
Earnings per share SEK	-0.04	-0.35	-0.07	-0.07	-0.11	-0.15	-0.34
Dividend per share SEK	0,00	0.00	0.00	0,00	0,00	0,00	0.00
Equity MSEK	8.16	7.26	7.26	9.90	12.70	5.56	7.81
Fixed assets MSEK	0.38	0.40	0.40	0.43	0.45	0.48	0.51
Intangible assets MSEK	0.33	0.39	0.39	0.46	0.55	0.64	0.74
Current assets MSEK	10.58	8.74	8.74	10.61	13.57	7.32	9.28
Total asset MSEK	11.28	9.53	9.53	11.50	14.57	8.44	10.53
Long term liabilities MSEK	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Current liabilities MSEK	3.12	2.27	2.27	1.60	1.87	2.88	2.72
Number of shares SEK	44304726.00	39167637.00	39167637.00	39167637.00	39167637.00	15167637.00	15167637.00